Position in TXG
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,932,457
New position
Shares Held
102,568
first reported quarter
Ownership
0.079%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $36,932,990 across 21 Medical Devices names. TXG ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
29,009 | $6,108,425 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
14,056 | $4,126,982 | |
| 3 | TXG |
10x Genomics, Inc.
This page
|
102,568 | $3,932,457 | |
| 4 | ENOV |
Enovis CORP
|
139,970 | $2,897,379 | |
| 5 | HAE |
Haemonetics Corp
|
36,844 | $2,763,300 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
22,024 | $2,619,754 | |
| 7 | ABT |
Abbott Laboratories
|
27,012 | $2,451,068 | |
| 8 | PODD |
Insulet Corp
|
12,102 | $1,842,529 |
All Filings in TXG
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,932,457 | 102,568 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||